๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants
NCT05133050Alport Syndrome
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
510
Shanghai
2022-01-01
Recruiting
Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients
NCT06572085Butylphthalide, Cardiac Arrest, Neuroprotective Drugs
Tang Ziren
Phase 4
350
Beijing
2022-01-01
Not yet open
Prospective Acute Myocardial Infarction Data Bank
NCT05121818Acute Myocardial Infarction
Shanghai Zhongshan Hospital
Observational
3,000
Shanghai
2022-01-01
Recruiting
UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors
NCT06760117Pediatric Solid Tumor
Sun Yat-sen University
Phase 1
39
Guangzhou
2022-01-01
By invitation
Effect of Hysteroscopic Metroplasty on Reproductive Outcome in Patients with RIF
NCT06847386Recurrent Implantation Failure, T-Shaped Uterus
Shanghai First Maternity and Infant Hospital
Not applicable
200
Shanghai
2022-01-01
Recruiting
Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer
NCT06391190Locally Advanced Cervical Carcinoma, Concurrent Chemoradiotherapy, Immunotherapy
RenJi Hospital
Phase 1/2
20
Shanghai
2022-01-01
Recruiting
Clinical Trial of BAO-G Technique in Complex Aortic Aneurysm Endovascular Repair (BAO-G-02)
NCT07141251Thoracoabdominal Aortic Aneurysm, Endovascular Repair, Complex Aortic Aneurysms
Peking Union Medical College Hospital
Phase 1
60
Beijing, Chongqing, Guangzhou, Haikou, Zhengzhou, Jining, Shanghai
2022-01-01
Recruiting
High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma
NCT07014943Primary Central Nervous System Lymphoma (PCNSL)
Sichuan University
Phase 2
34
Chengdu
2022-01-01
Recruiting
Multi-model Image of Doxycycline in TAO
NCT05112211Thyroid Associated Ophthalmopathy
Sun Yat-sen University
Not applicable
20
Guangzhou
2022-01-01
Recruiting
Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding
NCT04662918GastroIntestinal Bleeding
Xingshun Qi
Observational
3,000
Beijing, Fuzhou, Wuhan, Nanchang, Dalian, Shenyang, Xi'an, Jinan
2022-01-01
Not yet open
Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM
NCT05129774Colorectal Neoplasms Malignant, Lymph Node Excision, Chemoradiotherapy
Qilu Hospital of Shandong University
Not applicable
40
Jinan
2022-01-01
Recruiting
3D Depth Camera-Based Assessment of Adolescent Idiopathic ScoliosisUsing a Depth Camera
NCT06717568Adolescent Idiopathic Scoliosis
The First Affiliated Hospital of Zhejiang Chinese Medical University
Observational
80
Hangzhou
2022-01-01
Recruiting
China Lung Cancer Screening (CLUS) Study Version 3.0
NCT05494021Lung Cancer
Shanghai Chest Hospital
Not applicable
100,000
Shanghai
2022-01-01
Recruiting
ET-SPACE Whole-Body Infrared Hyperthermia in Patients With Advanced Solid Tumors
NCT07793214Advanced Solid Tumors, Advanced Solid Tumors Cancer
Zhejiang Hospital
Observational
500
Hangzhou
2022-01-01
Recruiting
IBD Biomarker Discovery and Validation Platform
NCT07686406Crohn Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Diseases (IBD)
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
6,000
Guangzhou
2022-01-01
Recruiting
An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
NCT05166070Solid Tumor
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1
24
Nanjing
2022-01-01
Recruiting
Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer
NCT05450029Rectal Cancer
Yanhong Deng
Phase 2
51
Guangzhou
2022-01-01
Recruiting
Oriental Research AlliaNce of Acute Ischemic Stroke Given Endovascular Treatment
NCT05024292Ischemic Stroke
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Observational
160
Zhangzhou, Shanghai
2022-01-01
By invitation
Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
NCT05338866Rectal Cancer
Sun Yat-sen University
Observational
58
Guangzhou
2022-01-01
Recruiting
China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
NCT05498974Type1diabetes, Diabetes
Second Xiangya Hospital of Central South University
Observational
20,000
Lanzhou, Shenzhen, Haikou, Harbin, Luoyang, Changsha, Nanjing, Changzhi
2022-01-01
By invitation
Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in Adults With Irritable Bowel Syndrome Using Multimodal MRI and High-Throughput Sequencing
NCT07345377Irritable Bowel Syndrome (IBS), Pain, Depressive Disorder, Major, Moderate
The Affiliated Hospital of Hangzhou Normal University
Not applicable
160
Hangzhou
2022-01-01
Recruiting
Trial of Flexible Bracing Treatment of Adolescents Idiopathic Scoliosis
NCT04116723Scoliosis
The Hong Kong Polytechnic University
Not applicable
100
Hong Kong
2022-01-01
Recruiting
Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy with 177Lu-EB-FAPI
NCT05400967177Lu-EB-FAPI
Peking Union Medical College Hospital
Phase EARLY_PHASE1
10
Beijing
2022-01-01
Recruiting
Clinical Registration Study of Patients With Intracranial / Carotid Stenosis
NCT05322824Cognitive Function, Stenosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
500
Hangzhou
2022-01-01
Recruiting
Radical Radiotherapy Versus Radical Surgery for UTUC
NCT06652009Renal Pelvis Cancer
Peking University First Hospital
Observational
60
Beijing
2022-01-01
Recruiting
PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer
NCT05236972Colorectal Carcinoma
Sun Yat-sen University
Phase 3
323
Guangzhou
2022-01-01
Recruiting
Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy
NCT05674305Nasopharyngeal Carcinoma
Fudan University
Phase 3
366
Shanghai
2022-01-01
Active, closed
Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC
NCT06569420Non-Small Cell Lung Cancer, ALK-positive, SAF-189s
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 3
275
Shanghai
2021-12-31
Not yet open
Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD
NCT05169021Cerebral Small Vessel Diseases, Stroke
Beijing Tiantan Hospital
Phase 4
15,000
Beijing
2021-12-31
Recruiting
Effect of RT3D-TEE-guided Mitral Valve Repair on Outcomes in Patients With Degenerative Mitral Valve Disease
NCT05595226Degenerative Mitral Valve Disease
Sheng Liu
Not applicable
338
Beijing
2021-12-31
Recruiting
Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer
NCT05541367Breast Cancer, TNBC - Triple-Negative Breast Cancer, Estrogen-receptor-negative Breast Cancer
Tongji Hospital
Observational
80
Wuhan
2021-12-31
Recruiting
ACOART BTK RENEW๏ผšA Post Market Clinical Study
NCT04885985Peripheral Artery Disease
Acotec Scientific Co., Ltd
Not applicable
107
Beijing
2021-12-31
Active, closed
Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug
NCT05203679Hemophilia B
Shanghai Xinzhi BioMed Co., Ltd.
Phase 2/3
32
Hefei, Beijing, Guangzhou, Shenzhen, Tangshan, Zhengzhou, Taiyuan, Tianjin
2021-12-30
By invitation
A Cohort Study on Cardiovascular and Cerebrovascular Outcomes
NCT07178015Stroke, Atheroscleroses
Sun Yat-sen University
Observational
855
Guangzhou
2021-12-30
By invitation
A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients
NCT05441475Hepatocellular Carcinoma
Abbisko Therapeutics Co, Ltd
Phase 2
118
Hubei
2021-12-30
Recruiting
Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma
NCT05170503Esophagogastric Junction Adenocarcinoma
Sun Yat-sen University
Phase 2
37
Guangzhou
2021-12-29
Active, closed
HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study
NCT05167071Solid Tumors, Neuroendocrine Tumors, CRC
Harbour BioMed (Guangzhou) Co. Ltd.
Phase 1
53
Beijing
2021-12-28
Recruiting
Respiratory Virus Metagenomics After COVID-19
NCT05126589COVID-19 Respiratory Infection
Chinese University of Hong Kong
Observational
500
Hong Kong
2021-12-28
Active, closed
Lorlatinib Continuation Study
NCT05144997Non-Small-Cell Lung Cancer, NSCLC
Pfizer
Phase 4
76
Hefei, Beijing, Fuzhou, Guangzhou, Changsha, Nanjing, Changchun, Hangzhou
2021-12-28
Active, closed
A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer
NCT05026905Phase II, Open-label, Parallel 2-arm, Multi-center
National Health Research Institutes, Taiwan
Phase 2
66
2021-12-28
Recruiting
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
NCT05147467Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Ascentage Pharma Group Inc.
Phase 2
75
Guangzhou, Haikou, Zhengzhou, Wuhan, Suzhou, Nanchang, Tianjin, Hanzhou
2021-12-28
Recruiting
A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
NCT05188885Chronic Kidney Disease
Guangdong Provincial People's Hospital
Observational
90,000
Foshan, Guangzhou, Meizhou, Qingyuan, Zhuhai, Ganzhou
2021-12-27
Active, closed
Crizotinib Continuation Clinical Study
NCT05160922NSCLC, ALCL, IMT
Pfizer
Phase 4
27
Beijing, Fuzhou, Guangzhou, Changchun, Wuhou District, Hangzhou, Shanghai
2021-12-27
Recruiting
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
NCT04925479Myeloid Leukemia, Philadelphia Positive
Novartis Pharmaceuticals
Phase 1/2
34
Hangzhou, Beijing, Shanghai, Tianjin
2021-12-27
Active, closed
A Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCC
NCT05054439Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
45
Guilin, Guiyang, Wuhan, Changsha, Shanghai, Chengdu, Hangzhou
2021-12-22
Recruiting
Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death
NCT06856993Sudden Cardiac Death, Exosome Multiomics, Clinical Prognosis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
300
Nanjing
2021-12-22
Recruiting
The Clinical Efficacy of Immunomodulators in RA Patients
NCT05626348Arthritis, Rheumatoid
Qilu Hospital of Shandong University
Phase 4
400
Jinan
2021-12-22
Recruiting
Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma
NCT05209620Central Nervous System Lymphoma
Henan Cancer Hospital
Phase 2
30
Zhengzhou
2021-12-21
Active, closed
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
NCT04919226Neuroendocrine Tumors
ITM Solucin GmbH
Phase 3
259
Shanghai, Wuxi
2021-12-21
Recruiting
S086 Tablets for Chronic Heart Failure With Reduced Ejection Fraction
NCT05553886Chronic Heart Failure With Reduced Ejection Fraction
Shenzhen People's Hospital
Phase 3
5
Shenzhen
2021-12-21
Recruiting
Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer
NCT05159193Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
372
Guandong
2021-12-20
Recruiting
Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
NCT04921527Ovarian Cancer, Relapsed or Refractory, Chiauranib, Paclitaxel
Chipscreen Biosciences, Ltd.
Phase 3
454
Shanghai
2021-12-20
Active, closed
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT04819100Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company
Phase 3
152
Beijing, Fuzhou, Guangzhou, Harbin, Changsha, Changchun, Xi'an, Jinan
2021-12-20
Active, closed
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (ฮฑ- or ฮฒ-NTDT)
NCT04770753Non-Transfusion-dependent Alpha-Thalassemia, Non-Transfusion-dependent Beta-Thalassemia
Agios Pharmaceuticals, Inc.
Phase 3
194
2021-12-20
By invitation
An Immunity Persistence Study of Live Attenuated Varicella Vaccine
NCT05095701Varicella
Sinovac (Dalian) Vaccine Technology Co., Ltd.
Phase 4
703
Xuchang, Zhumadian
2021-12-18
Recruiting
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
NCT05067283Advanced Solid Tumors
Merck Sharp & Dohme LLC
Phase 1
830
Beijing, Fuzhou, Guangzhou, Wuhan, Changchun, Shanghai, Hangzhou
2021-12-17
By invitation
Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors
NCT05423977HER2-positive Advanced Solid Tumor
Hangzhou Adcoris Biopharmacy Co., Ltd
Phase 1
36
Zigong
2021-12-17
Active, closed
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
NCT05097287Asthma
Sanofi
Phase 4
1,339
Beijing, Dongguan, Guangzhou, Guiyang, Hebei, Hefei, Nanchang, Nanjing
2021-12-16
Active, closed
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)
NCT05147220Relapsing Multiple Sclerosis
Novartis Pharmaceuticals
Phase 3
1,000
Guangzhou, Zhengzhou, Changsha, Baotou, Hohhot, Nanchang, Changchun, Beijing
2021-12-16
Recruiting
China National Registry of Neuro-Inflammatory Diseases
NCT05154370Multiple Sclerosis, NMO Spectrum Disorder, Clinically Isolated Syndrome, CNS Demyelinating Autoimmune Diseases
Beijing Tiantan Hospital
Observational
10,000
Beijing
2021-12-15
Active, closed
Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.
NCT05615142NSCLC, Low Dose Radiotherapy, Stereotactic Body Radiotherapy, PD-1 Inhibitor
Sichuan University
Phase 1
9
Chengdu
2021-12-15
Recruiting
Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation
NCT05136950Lens Implantation, Intraocular
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
228
Guangzhou
2021-12-14
Recruiting
Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases
NCT06316791Lupus Erythematosus, Systemic
Juventas Cell Therapy Ltd.
Phase EARLY_PHASE1
24
Zhengzhou
2021-12-14
Recruiting
The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder
NCT04984512Depressive Disorder, Major
Sunshine Lake Pharma Co., Ltd.
Phase 2/3
600
Dongguan
2021-12-14
Active, closed
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
NCT04954859Hepatitis B
GlaxoSmithKline
Phase 2
360
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Kunming, Liuzhou
2021-12-14
Active, closed
Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer
NCT04685070Non-small Cell Lung Cancer Stage III
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
56
Shanghai
2021-12-14
Active, closed
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
NCT05070858Generalized Myasthenia Gravis
Regeneron Pharmaceuticals
Phase 3
288
Beijing, Fuzhou, Guangdong, Guangzhou, Shenzhen, Haikou, Wuhan, Changsha
2021-12-14
Active, closed
SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma.
NCT05022654Esophageal Squamous Cell Carcinomas
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
22
Beijing, Anyang, Luoyang, Xuzhou, Taiyuan, Suining
2021-12-13
Active, closed
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)
NCT05156281Relapsing Multiple Sclerosis
Novartis Pharmaceuticals
Phase 3
1,007
Wuhan, Nanjing, Yinchuan, Taiyuan, Hangzhou, Wenzhou, Beijing, Shanghai
2021-12-13
Active, closed
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).
NCT05116189Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms
Merck Sharp & Dohme LLC
Phase 3
643
Hefei, Beijing, Fuzhou, Lanzhou, Guangzhou, Zhanjiang, Nanning, Haikou
2021-12-13
Recruiting
Corheart 6: Long-term Cohort Study
NCT07094919Heart Failure
China National Center for Cardiovascular Diseases
Not applicable
160
Shenzhen, Zhengzhou, Wuhan, Nanjing, Beijing, Shanghai
2021-12-12
Recruiting
Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer
NCT05202314Colorectal Cancer, Neoadjuvant Chemotherapy, Stent, Obstruction
Beijing Chao Yang Hospital
Not applicable
20
Beijing
2021-12-12
By invitation
TRIM25 in Septic Patients
NCT07320638Sepsis
Ruijin Hospital
Observational
65
Shanghai
2021-12-10
Recruiting
Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms
NCT05000892Salivary Gland Malignant Neoplasms, Salivary Gland Tumors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
15
Guangzhou
2021-12-10
Active, closed
RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee
NCT05318521Degenerative Arthritis
Overseas Pharmaceuticals, Ltd.
Phase 3
500
2021-12-10
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
NCT04892173Carcinoma, Squamous Cell
Johnson & Johnson Enterprise Innovation Inc.
Phase 3
500
Bengbu, Changsha, Chengdu, Dongguan, Fuzhou, Guangzhou, Jinan, Linyi
2021-12-10
Recruiting
A Clinical Study on TIL for the Treatment of Advanced Solid Tumors
NCT05087745Advanced Solid Tumor, Tumor Infiltrating Lymphocytes, Treatment Side Effects, Effects of Immunotherapy
Shanghai Juncell Therapeutics
Phase EARLY_PHASE1
50
Hangzhou
2021-12-10
Active, closed
Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma
NCT05106777Sarcoma
Sun Yat-sen University
Phase 2
47
Guangzhou
2021-12-10
Recruiting
Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer
NCT05751018Non-small Cell Lung Cancer
Peking Union Medical College Hospital
Phase 2
18
Beijing
2021-12-08
Recruiting
Idebenone for the Preventive Treatment of Migraine
NCT04151472Migraine Disorders, Headache Disorders
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
180
Hangzhou
2021-12-08
Recruiting
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
NCT05077904Stereotypical Prolonged Seizures
UCB Biopharma SRL
Phase 3
350
Beijing, Changchun, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Kunming
2021-12-07
Active, closed
Long-term Efficacy and Safety Study of GV-971
NCT05181475Alzheimer Disease
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Phase 4
800
Beijing, Chongqing, Lanzhou, Foshan, Guangzhou, Shenzhen, Guiyang, Baoding
2021-12-07
Active, closed
Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)
NCT05002777Warm Autoimmune Hemolytic Anemia (wAIHA)
Sanofi
Phase 2
22
Beijing, Tianjin
2021-12-07
Active, closed
SI-B001 Combined With Chemotherapy in the Treatment of EGFR/ALK WT Recurrent or Metastatic NSCLC.
NCT05020457Non Small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
69
Chongqing, Guangzhou, Guilin, Jinan, Taizhou
2021-12-07
Recruiting
Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer
NCT05072600Bladder Cancer, Bladder Neoplasms, Bladder Tumors, Urinary Bladder Cancer
Peking University First Hospital
Phase 2
54
Beijing
2021-12-07
Recruiting
A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors
NCT04996121Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic Non-small Cell Lung Cancer
Xuanzhu Biopharmaceutical Co., Ltd.
Phase 1/2
360
Beijing
2021-12-06
Active, closed
A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer
NCT04950322Gastric or Gastroesophageal Junction Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
737
Beijing
2021-12-06
Active, closed
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
NCT05152147Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma
Jazz Pharmaceuticals
Phase 3
920
Beijing, Bengbu, Changsha, Changzhi, Changzhou, Chengdu, Fuzhou, Guangzhou
2021-12-02
Active, closed
Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection
NCT05307835Resectable Esophageal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
27
Hangzhou
2021-12-02
Recruiting
Clinical Pharmacology of Dexamethasone in Pregnant Women With Preterm Labor
NCT05207852Respiratory Distress Syndrome of Newborn, Threatened Premature Labor, Antepartum
Dongyang Liu
Observational
288
Beijing
2021-12-01
Active, closed
An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)
NCT05112965Neoplasms
Hoffmann-La Roche
Phase 3
49
Guangzhou, Harbin, Wuhan, Jinan, Hangzhou, Beijing, Changchun, Changsha
2021-12-01
Recruiting
A Cohort of Patients Undergoing Percutaneous Coronary Intervention
NCT05719545Acute Coronary Syndrome, Percutaneous Coronary Intervention, Myocardial Infarction, Unstable Angina
Su Guohai
Observational
10,000
Jinan
2021-12-01
Recruiting
The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study
NCT04957901Lymphoma
Sun Yat-sen University
Observational
60
Guangzhou
2021-12-01
Recruiting
Diagnosis and Comprehensive Treatment of Mediastinal Interventional Technique
NCT06128681Mediastinal Diseases
Dan Liu
Observational
30
Tianjin
2021-12-01
Recruiting
Minocycline for Chronic Autoimmune Uveitis
NCT05474729Minocycline, Uveitis, Retinal Degeneration
Sun Yat-sen University
Phase 1/2
10
Guangzhou
2021-12-01
Recruiting
Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.
NCT05284318Periprosthetic Joint Infection, Anti-Bacterial Agents
First Affiliated Hospital of Fujian Medical University
Observational
500
Fuzhou
2021-12-01
Recruiting
Correlation Between the Changes of Retinal Structure and Function and Ischemic Stroke
NCT05281887Ischemic Stroke
Guangdong Provincial People's Hospital
Observational
120
Guangzhou
2021-12-01
Recruiting
Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China
NCT06655090Interstitial Lung Disease (ILD)
Dai Huaping
Observational
10,000
Beijing
2021-12-01
Recruiting
Antiviral Therapy for Patients With Liver Cancer After Surgery
NCT05466565Hepatocellular Carcinoma
Xiangya Hospital of Central South University
Observational
360
Changsha
2021-12-01
Recruiting
Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated Cardiomyopathy
NCT07527715Cardiomyopathy, Dilated, Prognosis, Magnetic Resonance Imaging, Cardiac, Death, Sudden, Cardiac
Shandong Provincial Hospital
Observational
2,000
Jinan
2021-12-01
Rows per page Showing 17001–17100 of 19052
Previous 169 170 171 172 173 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=171

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.